Seller record · Telehealth service

DoctorAdam

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The semaglutide page calls the product compounded semaglutide, and no page states that a compounded drug is not FDA-approved. The weight loss page compares semaglutide tablets with Ozempic and marks both as having an FDA-approved active ingredient. 1 more criterion also fails; see the table below.

At a glance

DoctorAdamTelehealth service

6/8criteria passed
Price
Semaglutide from $129, tirzepatide from $199
Sells
compounded semaglutide injection, semaglutide oral tablets, and 11 more
FDA letters
None on file
Visit DoctorAdamSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide as injections, tablets and drops, compounded tirzepatide as injections and tablets, Wegovy, and sermorelin, NAD+ and PT-141, alongside sexual health, hair and sleep treatments. It prints starting prices only, names two filling pharmacies, and no page states that a compounded drug is not FDA-approved.

Operating entity Nodomo LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSDoctorAdam's FAQ; DoctorAdam's semaglutide page
S2Prescription gatingPASSDoctorAdam's FAQ; DoctorAdam's semaglutide page
S3Pharmacy identificationPASSDoctorAdam's FAQ
S4Compounding disclosureFAILDoctorAdam's semaglutide page; DoctorAdam's weight loss page; DoctorAdam's FAQ
S5Analytical documentationFAILDoctorAdam's semaglutide page; DoctorAdam's FAQ; DoctorAdam's lab testing page
S6Business addressPASSDoctorAdam's terms of use page; DoctorAdam's privacy policy; DoctorAdam's contact page
S7Price disclosurePASSDoctorAdam's weight loss page; DoctorAdam's tirzepatide injection page; DoctorAdam's Wegovy product page; DoctorAdam's longevity page; DoctorAdam's product page; DoctorAdam's FAQ
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSU.S.-based doctors review each patient's medical answers and prescribe only as necessary, and the product pages name the prescribing physicians and nurse practitioners.Source: DoctorAdam's FAQ; DoctorAdam's semaglutide page.
S2PASSThe answers say the buyer chooses a therapy, presses the start button and answers a brief set of medical questions that a doctor reviews before prescribing, and the start buttons lead to the patient portal's intake form. The product pages say the purchase is for a consultation, refunded in full if nothing is prescribed.Source: DoctorAdam's FAQ; DoctorAdam's semaglutide page.
S3PASSThe answers page names two partner pharmacies with their addresses: Olympia Pharmaceuticals at 4600 L B McLeod Rd, Orlando, FL 32811, and Carie Boyd Pharmaceuticals at 8400 Esters Blvd Ste 190, Irving, TX 75063.FDA warning letter 694687 is addressed to Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals, a pharmacy named here.Source: DoctorAdam's FAQ.
S4FAILThe semaglutide page calls the product compounded semaglutide, and no page states that a compounded drug is not FDA-approved. The weight loss page compares semaglutide tablets with Ozempic and marks both as having an FDA-approved active ingredient.Source: DoctorAdam's semaglutide page; DoctorAdam's weight loss page; DoctorAdam's FAQ.
S5FAILNo certificate of analysis or lot document is published on the product pages, the answers or the policies. The lab testing page sells blood panels for patients.Source: DoctorAdam's semaglutide page; DoctorAdam's FAQ; DoctorAdam's lab testing page.
S6PASSNodomo LLC, trading as DoctorAdam, at 1475 S State College Blvd, Anaheim, CA 92806, printed in the terms, the privacy policy and the footer of every page.Source: DoctorAdam's terms of use page; DoctorAdam's privacy policy; DoctorAdam's contact page.
S7PASSEach product prints a from price and no plan price beside it: semaglutide injection, tablets and drops from $129, tirzepatide tablets from $199, tirzepatide injection from $229, Wegovy from $279, the sermorelin injection from $149, the NAD+ injection from $129 and PT-141 from $99, with other NAD+ and sermorelin products from $139 to $279. The answers page gives a range of $199 to $1,349 a month.Source: DoctorAdam's weight loss page; DoctorAdam's tirzepatide injection page; DoctorAdam's Wegovy product page; DoctorAdam's longevity page; DoctorAdam's product page; DoctorAdam's FAQ.
S8PASSNo FDA warning letter names DoctorAdam or Nodomo LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, semaglutide oral tablets, semaglutide drops, tirzepatide injection, tirzepatide oral tablets, Wegovy, Foundayo, sermorelin injectable, Vitality Basic and Vitality Restore sermorelin, NAD+ injectable, Revive NAD+ and NAD+ nasal spray, PT-141 (bremelanotide) strips, B12 and MICC-B12 injections.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141

A warning letter to a pharmacy this seller names

FDA warning letter 694687, issued December 2024, to Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals“During the inspection, the investigator noted that drug products you produced failed to meet the conditions of section 503B of the FDCA necessary for drugs produced by an outsourcing facility to qualify for exemptions from certain provisions of the FDCA.”

The letter is addressed to the pharmacy, not to DoctorAdam, and changes no disposition on this record.

Visit DoctorAdam

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.